Epidemiologia

MDPI AG

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Epidemiologia is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,200 CHF. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
2673-3986
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,200 CHF
Articles in DOAJ
384
Declared review time
7 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2021-06-02
  • PUBMED · 2020-08-06
Indexing
DOAJ · PUBMED
APC
1,200 CHF
Declared review time (DOAJ)
7 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

384

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

7weeks

Works in OpenAlex

369

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

21

i10-index

65

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-10
Added to DOAJ
2021-06-02
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
100%
ORCID iDs in current deposits
98%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918333886406676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine

LCC codes

RC31-1245

Subject areas

  • COVID-19 epidemiological studies
  • COVID-19 epidemiological studies
  • COVID-19 epidemiological studies
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • Vaccine Coverage and Hesitancy
Show all subjects (75)
  • Vaccine Coverage and Hesitancy
  • COVID-19 Clinical Research Studies
  • COVID-19 and Mental Health
  • COVID-19 and Mental Health
  • Mathematical and Theoretical Epidemiology and Ecology Models
  • COVID-19 Clinical Research Studies
  • Data-Driven Disease Surveillance
  • Global Cancer Incidence and Screening
  • COVID-19 Pandemic Impacts
  • COVID-19 Clinical Research Studies
  • COVID-19 Pandemic Impacts
  • Data-Driven Disease Surveillance
  • Data-Driven Disease Surveillance
  • COVID-19 and Mental Health
  • Zoonotic diseases and public health
  • Zoonotic diseases and public health
  • COVID-19 Prevention and Impact
  • COVID-19 and healthcare impacts
  • Health disparities and outcomes
  • Health disparities and outcomes
  • COVID-19 and healthcare impacts
  • Obesity, Physical Activity, Diet
  • Obesity, Physical Activity, Diet
  • Obesity, Physical Activity, Diet
  • Chronic Disease Management Strategies
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • Global Cancer Incidence and Screening
  • Respiratory viral infections research
  • Chronic Disease Management Strategies
  • Physical Activity and Health
  • Viral Infections and Outbreaks Research
  • Mosquito-borne diseases and control
  • Global Cancer Incidence and Screening
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Influenza Virus Research Studies
  • Animal Disease Management and Epidemiology
  • Health disparities and outcomes
  • SARS-CoV-2 detection and testing
  • Viral Infections and Outbreaks Research
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 detection and testing
  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 detection and testing
  • Mosquito-borne diseases and control
  • Mosquito-borne diseases and control
  • Global Maternal and Child Health
  • Infection Control and Ventilation
  • Geriatric Care and Nursing Homes
  • Viral Infections and Vectors
  • Infection Control and Ventilation
  • Global Maternal and Child Health
  • COVID-19 and healthcare impacts
  • Virology and Viral Diseases
  • Dental Health and Care Utilization
  • Geriatric Care and Nursing Homes
  • Long-Term Effects of COVID-19
  • Yersinia bacterium, plague, ectoparasites research
  • Long-Term Effects of COVID-19
  • Viral Infections and Vectors
  • Respiratory viral infections research
  • Bacterial Infections and Vaccines
  • Yersinia bacterium, plague, ectoparasites research
  • Infection Control in Healthcare
  • Acute Ischemic Stroke Management
  • Vector-borne infectious diseases
  • Physical Activity and Health

Keywords (DOAJ)

  • infectious disease epidemiology
  • clinical epidemiology
  • biostatistics
  • global health
  • infectious diseases
  • environmental epidemiology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: